Identifying stage B colorectal cancer patients at high risk of tumor recurrence and death

Diseases of the Colon and Rectum

Volumn 40, Issue 3, 1997, Pages 326-331

  Mulcahy, Hugh E ^a,b   Toner, Mary ^a   Patchett, Stephen E ^a   Daly, Leslie ^a   O'Donoghue, Diarmuid P ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adjuvant therapy; Colorectal neoplasms; Prognosis; Staging

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RECURRENCE RISK; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SINGLE-BLIND METHOD; SURVIVAL ANALYSIS;

EID: 0030936150     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02050424     Document Type: Article

References (44)

1. Davis NC, Newland RC. Terminology and classification of colorectal adenocarcinoma: the Australian clinicopathological staging system. Aust N Z J Surg 1983;53: 211-21.
2. Moertel CG, Fleming TR, Macdonald JS. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-8.
3. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 1995;345:939-44.
4. Swiss Group for Clinical Cancer Research (SAKK). Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Lancet 1995; 345:349-53.
5. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal cancer liver metastases. Lancet 1994;344:1255-60.
6. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954;139:846-51.
7. Chapuis PH, Dent OF, Fisher R, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985;72:698-702.
8. Nauta R, Stablein DM, Holyoke D. Survival of patients with stage B2 colon carcinoma: the Gastrointestinal Tumor Study Group experience. Arch Surg 1989;124: 180-2.
9. Clouse LH. Adjuvant chemotherapy in colorectal cancer: mournful, hopeful perpetual motion machine heads to dim light at end of tunnel. JAMA 1989;261: 987-8.
10. Freedman LS. Tables of the number of patients required in clinical trials using the logrank test. Stat Med 1982;1: 121-9.
11. Fielding LP, Stewart-Brown S, Blesovsky L. Large-bowel obstruction caused by cancer: a prospective study. BMJ 1979;2:515-7.
12. Sasaki O, Atkin WS, Jass JR. Mucinous carcinoma of the rectum. Histopathology 1987;11:259-72.
13. Fisher ER, Palekar AS, Gregorio RM, Redmond C, Fisher B. Pathological findings from the national surgical adjuvant breast project (protocol no. 4). IV. Significance of tumor necrosis. Hum Pathol 1978;9:523-30.
14. Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet 1987;1:1303-6.
15. Krasna MJ, Flancbaum L, Cody RP, Shneibaum S, Ben Ari G. Vascular and neural invasion in colorectal cancer. Cancer 1988;61:1018-23.
16. Khankhanian N, Mavligit GM, Russell WO, Schimek M. Prognostic significance of vascular invasion in colorectal cancer of Dukes' B class. Cancer 1977;39:1195-2000.
17. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley and Sons, 1980.
18. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932;35:323-32.
19. Turnbull RB. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg 1967;166:420-7.
20. Engel HC. Cancer cells in the blood, a five to nine year follow up study. Ann Surg 1959;149:457-61.
21. Lindeman F, Schlimok G, Dirschedl P, Witte J, Riethmuller G. Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal cancer patients. Lancet 1992;340:685-9.
22. Wied U, Nilsson T, Knudsen JB, Sprechler M, Johansen A. Postoperative survival of patients with potentially curable cancer of the colon. Dis Colon Rectum 1985;28: 333-5.
23. Talbot IC, Ritchie S, Leighton M, Hughes A, Bussey H, Morson B. The clinical significance of invasion of veins by rectal cancer. Br J Surg 1980;67:439-42.
24. Horn A, Dahl O, Morild I. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis Colon Rectum 1991;34:798-804.
25. Costa J, Wesley RA, Glatstein E, Rosenberg SA. The grading of soft tissue sarcomas: results of a clinicohistopathologic correlation in a series of 163 cases. Cancer 1984;53:530-41.
26. Parham DM, Hagen N, Brown RA. Simplified method of grading primary carcinomas of the breast. J Clin Pathol 1992;45:517-20.
27. Tsujimoto M, Aozasa K, Ueda T, Morimura Y, Komatsubara Y, Doi TI. Multivariate analysis for histologic prognostic factors in soft tissue sarcomas. Cancer 1988; 62:994-8.
28. Parham DM, Robertson AJ, Brown RA. Morphometric analysis of breast carcinoma: association with survival. J Clin Pathol 1988;41:173-7.
29. Robbins SL, Angell M. Basic pathology. 2nd ed. Philadelphia: WB Saunders, 1976:1-30.
30. Mulcahy HE, Duffy MJ, Gibbons D, et al. Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer. Lancet 1994;344:583-4.
31. Duffy MJ. The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis 1992;10: 144-55.
32. Tryggvason K, Hoyhtya M, Salo T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 1987;907:191-217.
33. Bear HD, MacIntyre J, Burns HJ, Jarrett F, Wilson RE. Colon and rectal carcinoma in the west of Scotland: symptoms, histological characteristics, and outcome. Am J Surg 1984;147:441-6.
34. Fielding LP, Phillips RK, Hittinger R. Factors influencing mortality after curative resection for large bowel cancer in elderly patients. Lancet 1989;2:904-7.
35. Anderson JH, Hole D, McArdle CS. Elective versus emergency surgery for patients with colorectal cancer. Br J Surg 1992;79:706-9.
36. Phillips RK. Clinical factors which influence outcome after colorectal cancer surgery. In: Phillips R, Northover J, eds. Modern coloproctology: surgical grand rounds from St Mark's Hospital. London: Edward Arnold, 1993: 69-79.
37. Welch JP, Donaldson GA. Management of severe obstruction of the large bowel due to malignant disease. Am J Surg 1974;127:492-9.
38. Willet C, Tepper JE, Cohen A, Orlow E, Welch C. Obstructive and perforative colonic carcinoma: patterns of failure. J Clin Oncol 1985;3:379-84.
39. Runkel NS, Schlag P, Schwarz V, Herfarth C. Outcome after emergency surgery for cancer of the large intestine. Br J Surg 1991;78:183-8.
40. Krook JE, Moertel CG, Gunderson LL. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-15.
41. Mulder JW, Kruyt PM, Sewnath M, et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994;344:1470-2.
42. Ganesh S, Sier CF, Griffioen G, et al. Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Cancer Res 1994;54:4065-71.
43. Jen J, Kim H, Piantadosi S, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994;331:213-21.
44. Hamelin R, Laurent Puig P, Olschwang S, et al. Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 1994;106:42-8.